PRQR Stock Summary and Trading Ideas (Proqr Therapeutics N.V. - | NASDAQ:PRQR)

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Proqr Therapeutics N.V. - trades on the NASDAQ stock market under the symbol PRQR.

As of September 11, 2026, PRQR stock price climbed to $1.97 with 16,137 million shares trading.

PRQR has a beta of 2.60, meaning it tends to be more sensitive to market movements. PRQR has a correlation of 0.17 to the broad based SPY ETF.

PRQR has a market cap of $278.01 million. This is considered a Small Cap stock.

Last quarter Proqr Therapeutics N.V. - reported $10 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.05.

In the last 3 years, PRQR traded as high as $4.62 and as low as $1.07.

PRQR has underperformed the market in the last year with a price return of -12.4% while the SPY ETF gained +18.6%. However, in the short term, PRQR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +39.7% vs +5.8% return in SPY. But in the last 2 weeks, PRQR shares have been beat by the market, returning -15.1% compared to an SPY return of -0.7%.

PRQR support price is $1.85 and resistance is $2.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRQR shares will trade within this expected range on the day.